These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 37100606)

  • 1. Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
    Nakane T; Mitsuyama K; Yamauchi R; Kakuma T; Torimura T
    Kurume Med J; 2023 Jul; 68(2):43-52. PubMed ID: 37100606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment.
    Pizuorno Machado A; Shatila M; Glitza Oliva IC; Altan M; Siddiqui B; Zhou Y; Varatharajalu K; Zhang HC; Thomas A; Wang Y
    Am J Clin Oncol; 2023 Aug; 46(8):360-365. PubMed ID: 37219360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint Inhibitor-Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis.
    Nielsen DL; Juhl CB; Chen IM; Kellermann L; Nielsen OH
    Cancer Treat Rev; 2022 Sep; 109():102440. PubMed ID: 35917654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitors-Induced Colitis.
    Tian Y; Abu-Sbeih H; Wang Y
    Adv Exp Med Biol; 2018; 995():151-157. PubMed ID: 30539510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab.
    Zhang HC; Luo W; Wang Y
    J Immunother Cancer; 2019 Feb; 7(1):47. PubMed ID: 30777137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoint Inhibitor-Mediated Diarrhea and Colitis: A Clinical Review.
    Gong Z; Wang Y
    JCO Oncol Pract; 2020 Aug; 16(8):453-461. PubMed ID: 32584703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Checkpoint Inhibitor-associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies.
    Tran AN; Wang M; Hundt M; Chugh R; Ohm J; Grimshaw A; Ciarleglio M; Hung KW; Proctor DD; Price CC; Laine L; Al-Bawardy B
    J Immunother; 2021 Oct; 44(8):325-334. PubMed ID: 34380976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal Tract Adverse Events.
    Abu-Sbeih H; Wang Y
    Adv Exp Med Biol; 2020; 1244():247-253. PubMed ID: 32301019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of diarrhea and colitis in patients with lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
    Bishay K; Tandon P; Bourassa-Blanchette S; Laurie SA; McCurdy JD
    Curr Oncol; 2020 Oct; 27(5):e486-e494. PubMed ID: 33173388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Checkpoint Inhibitor-Induced Colitis: An Update.
    Losurdo G; Angelillo D; Favia N; Sergi MC; Di Leo A; Triggiano G; Tucci M
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival.
    Yamada K; Sawada T; Nakamura M; Yamamura T; Maeda K; Ishikawa E; Iida T; Mizutani Y; Kakushima N; Ishikawa T; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Furune S; Hase T; Yokota K; Maeda O; Hashimoto N; Akiyama M; Ando Y; Fujishiro M
    World J Gastroenterol; 2021 Nov; 27(41):7190-7206. PubMed ID: 34887637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint inhibitor-induced diarrhea and colitis: an overview.
    Zoghbi M; Burk KJ; Haroun E; Saade M; Carreras MTC
    Support Care Cancer; 2024 Sep; 32(10):680. PubMed ID: 39311981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid-resistant immune-related adverse events: a systematic review.
    Daetwyler E; Wallrabenstein T; König D; Cappelli LC; Naidoo J; Zippelius A; Läubli H
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38233099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis.
    Mooradian MJ; Wang DY; Coromilas A; Lumish M; Chen T; Giobbie-Hurder A; Johnson DB; Sullivan RJ; Dougan M
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review.
    Machado AP; Ratliff H; Abdelwahab A; Vohra MH; Kuang A; Shatila M; Khan MA; Shafi MA; Thomas AS; Philpott J; Alhalabi O; Wang Y
    J Cancer; 2023; 14(16):2956-2963. PubMed ID: 37859810
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report.
    Lu L; Sha L; Feng Y; Yan L
    World J Clin Cases; 2022 Dec; 10(35):13108-13114. PubMed ID: 36569020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma.
    Favara DM; Spain L; Au L; Clark J; Daniels E; Diem S; Chauhan D; Turajlic S; Powell N; Larkin JM; Yousaf N
    ESMO Open; 2020 Jul; 5(4):. PubMed ID: 32641348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
    Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S
    Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors.
    Dougan M; Blidner AG; Choi J; Cooksley T; Glezerman I; Ginex P; Girotra M; Gupta D; Johnson D; Shannon VR; Suarez-Almazor M; Anderson R; Rapoport BL
    Support Care Cancer; 2020 Dec; 28(12):6129-6143. PubMed ID: 32856210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitors in steroid and anti-TNF-alpha refractory immune checkpoint inhibitor colitis.
    Zhang E; Kiely C; Sandanayake N; Tattersall S
    JGH Open; 2021 May; 5(5):558-562. PubMed ID: 34013054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.